NCT06881017 Establishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular Subtyping Status NOT_YET_RECRUITING Phase PHASE2
NCT06872606 Short-Course Radiotherapy Combined with Intracavitary Brachytherapy Followed by Pucotenlimab, Bevacizumab, Oxaliplatin, and Trifluridine/Tipiracil (TAS-102) for Total Neoadjuvant Therapy of Microsatellite Stable (MSS) Locally Advanced Low Rectal Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06856447 The Role of Coenzyme Q10 in the Prophylaxis of Oxaliplatin Induced Peripheral Neuropathy in Patients With Colorectal Cancer Status RECRUITING Phase PHASE1
NCT06841679 Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma Status RECRUITING Phase PHASE2/PHASE3
NCT06840665 MR-guided Adaptive Radiotherapy Combined With PD-1 Antibody and CAPOX for Locally Advanced Rectal Cancer Status RECRUITING Phase PHASE2
NCT06839105 A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies Status RECRUITING Phase PHASE1
NCT06835387 Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors Status RECRUITING Phase PHASE2
NCT06825624 ARTEMIS-102: HS-20093 Combinations in Patients with Advanced Metastatic Colorectal Cancer Status RECRUITING Phase PHASE1
NCT06821997 NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial Status RECRUITING Phase PHASE2
NCT06820463 A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer Status RECRUITING Phase PHASE2
NCT06806033 A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Status RECRUITING Phase PHASE2
NCT06802666 Short-course Radiotherapy Followed by AK112 and CAPOX as Neoadjuvant Therapy for Locally Advanced Rectal Cancer Status RECRUITING Phase PHASE2
NCT06790212 Neoadjuvant CAPOX Plus Ivonescimab Versus CAPOX for Locally Advanced Colon Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06788171 PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM Status NOT_YET_RECRUITING Phase PHASE2
NCT06787183 SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases Status RECRUITING Phase PHASE2
NCT06782685 Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV Status RECRUITING Phase PHASE1/PHASE2
NCT06780787 FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery Status RECRUITING Phase PHASE2
NCT06780111 Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06) Status RECRUITING Phase PHASE1/PHASE2
NCT06771622 Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06764875 A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer Status RECRUITING Phase PHASE3